[HTML][HTML] Endoplasmic reticulum stress in airway hyperresponsiveness

Q Duan, Y Zhou, D Yang - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Airway hyperresponsiveness (AHR) is a major clinical phenomenon in lung diseases
(asthma, COPD and pulmonary fibrosis) and not only a high-risk factor for perioperative …

RAGE and TLR4 differentially regulate airway hyperresponsiveness: Implications for COPD

VSRR Allam, A Faiz, M Lam, SNH Rathnayake, B Ditz… - Allergy, 2021 - Wiley Online Library
Background The receptor for advanced glycation end products (RAGE) and Toll‐like
receptor 4 (TLR4) is implicated in COPD. Although these receptors share common ligands …

[HTML][HTML] New perspectives in pharmacological therapy for COPD: Phenotype classification and corticosteroids with bronchodilators

H Kume, R Yamada, Y Sato - A Compendium of Chronic …, 2022 - intechopen.com
Chronic obstructive lung disease (COPD) is heterogeneous and complex. Symptoms and
pathophysiological disorders overlap between COPD and asthma. To progress the …

[HTML][HTML] Chronisch-obstruktive Lungenerkrankung 2021–die richtige Therapie für den richtigen Patienten

H Olschewski, R Buhl, GC Funk, A Valipour… - Der …, 2021 - ncbi.nlm.nih.gov
In den vergangenen Jahren wurden auf dem Gebiet der chronisch-obstruktiven
Lungenerkrankung (COPD) große Therapiestudien publiziert, die 2020 um mehrere Post …

Chronic obstructive pulmonary disease: the right treatment for the right patient

H Olschewski, R Buhl, GC Funk, A Valipour… - Der Internist, 2021 - Springer
In recent years, large treatment studies have been published in the field of chronic
obstructive pulmonary disease (COPD) and were supplemented by several post-hoc …

[PDF][PDF] VI ICS Usage in Real Practice and Appropriate Treatment

조민주, 문지용 - 김현정(계명대학교의과대학동산병원호흡기내과), 2021 - oldrf.org
Recently, limited use of Inhaled corticosteroid (ICS) in COPD patients is recommended. In
the treatment of COPD, ICS was shown to be effective in improving pulmonary function and …